Yasuhiro Koh
About
Yasuhiro Koh is a scholar working on Infectious Diseases, Virology and Molecular Biology.
According to data from OpenAlex, Yasuhiro Koh has authored 40 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Infectious Diseases, 32 papers in Virology and 13 papers in Molecular Biology. Recurrent topics in Yasuhiro Koh's work include HIV/AIDS drug development and treatment (34 papers), HIV Research and Treatment (32 papers) and HIV/AIDS Research and Interventions (8 papers). Yasuhiro Koh is often cited by papers focused on HIV/AIDS drug development and treatment (34 papers), HIV Research and Treatment (32 papers) and HIV/AIDS Research and Interventions (8 papers). Yasuhiro Koh collaborates with scholars based in United States, Japan and Australia. Yasuhiro Koh's co-authors include Hiroaki Mitsuya, Arun K. Ghosh, Kenji Maeda, Debananda Das, Alan Engelman, Masayuki Amano, Irene T. Weber, Hirotomo Nakata, Hiromi Ogata and D. Eric Walters and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Virology.
In The Last Decade
Yasuhiro Koh
39 papers receiving 2.4k citations
Peers
Yasuhiro Koh
W. Gary Tarpley United States
Debananda Das United States
J C Quintero United States
Marc Witmer United States
Jill C. Heimbach United States
Manos Perros United Kingdom
Lori J. Gabryelski United States
William E. Kohlbrenner United States
Sudthida Vasavanonda United States
Simon Cocklin United States
Citations per year, relative to Yasuhiro Koh Yasuhiro Koh (= 1×)
peers
W. Gary Tarpley
Countries citing papers authored by Yasuhiro Koh
Since
Specialization
Citations
This map shows the geographic impact of Yasuhiro Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuhiro Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuhiro Koh more than expected).
Fields of papers citing papers by Yasuhiro Koh
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Yasuhiro Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuhiro Koh. The network helps show where Yasuhiro Koh may publish in the future.
Co-authorship network of co-authors of Yasuhiro Koh
This figure shows the co-authorship network connecting the top 25 collaborators of Yasuhiro Koh. A scholar is included among the top collaborators of Yasuhiro Koh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuhiro Koh. Yasuhiro Koh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Amano, Masayuki, Haydar Bulut, Sadahiro Tamiya, et al.. (2019). Amino-acid inserts of HIV-1 capsid (CA) induce CA degradation and abrogate viral infectivity: Insights for the dynamics and mechanisms of HIV-1 CA decomposition. Scientific Reports. 9(1). 9806–9806.
2.
Chitty, Jessica L., Simon J. Williams, Yasuhiro Koh, et al.. (2017). GMP Synthase Is Required for Virulence Factor Production and Infection by Cryptococcus neoformans. Journal of Biological Chemistry. 292(7). 3049–3059.
3.
Chitty, Jessica L., Yasuhiro Koh, Avril A. B. Robertson, et al.. (2017). Cryptococcus neoformans ADS lyase is an enzyme essential for virulence whose crystal structure reveals features exploitable in antifungal drug design. Journal of Biological Chemistry. 292(28). 11829–11839.
4.
Williams, Simon J., Samantha D. M. Arras, Jessica L. Chitty, et al.. (2016). Disruption of de Novo Adenosine Triphosphate (ATP) Biosynthesis Abolishes Virulence in Cryptococcus neoformans. ACS Infectious Diseases. 2(9). 651–663.
5.
Hayashi, Hironori, Nobutoki Takamune, Takashi Nirasawa, et al.. (2014). Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavir. Proceedings of the National Academy of Sciences. 111(33). 12234–12239.
6.
Feng, Lei, Amit Sharma, Alison Slaughter, et al.. (2013). The A128T Resistance Mutation Reveals Aberrant Protein Multimerization as the Primary Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors. Journal of Biological Chemistry. 288(22). 15813–15820.
7.
Kessl, Jacques J., Nivedita Jena, Yasuhiro Koh, et al.. (2012). Multimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors. Journal of Biological Chemistry. 287(20). 16801–16811.
8.
Aoki, Manabu, Matthew Danish, Masayuki Amano, et al.. (2012). Loss of the Protease Dimerization Inhibition Activity of Tipranavir (TPV) and Its Association with the Acquisition of Resistance to TPV by HIV-1. Journal of Virology. 86(24). 13384–13396.
9.
Koh, Yasuhiro, Xiaolin Wu, Andrea L. Ferris, et al.. (2012). Differential Effects of Human Immunodeficiency Virus Type 1 Capsid and Cellular Factors Nucleoporin 153 and LEDGF/p75 on the Efficiency and Specificity of Viral DNA Integration. Journal of Virology. 87(1). 648–658.
10.
Aoki, Manabu, Masayuki Amano, Yasuhiro Koh, et al.. (2011). Novel HIV-1 Protease Inhibitors (PIs) Containing a Bicyclic P2 Functional Moiety, Tetrahydropyrano-Tetrahydrofuran, That Are Potent against Multi-PI-Resistant HIV-1 Variants. Antimicrobial Agents and Chemotherapy. 55(4). 1717–1727.
11.
Ghosh, Arun K., Bruno D. Chapsal, Abigail Baldridge, et al.. (2010). Design and Synthesis of Potent HIV-1 Protease Inhibitors Incorporating Hexahydrofuropyranol-Derived High Affinity P2 Ligands: Structure−Activity Studies and Biological Evaluation. Journal of Medicinal Chemistry. 54(2). 622–634.
12.
Ghosh, Arun K., Sandra Gemma, Elena Simoni, et al.. (2009). Synthesis and biological evaluation of novel allophenylnorstatine-based HIV-1 protease inhibitors incorporating high affinity P2-ligands. Bioorganic & Medicinal Chemistry Letters. 20(3). 1241–1246.
13.
Nakata, Hirotomo, Seth M. Steinberg, Yasuhiro Koh, et al.. (2008). Potent Synergistic Anti-Human Immunodeficiency Virus (HIV) Effects Using Combinations of the CCR5 Inhibitor Aplaviroc with Other Anti-HIV Drugs. Antimicrobial Agents and Chemotherapy. 52(6). 2111–2119.
14.
Koh, Yasuhiro, Shintaro Matsumi, Debananda Das, et al.. (2007). Potent Inhibition of HIV-1 Replication by Novel Non-peptidyl Small Molecule Inhibitors of Protease Dimerization. Journal of Biological Chemistry. 282(39). 28709–28720.
15.
Nakata, Hirotomo, Masayuki Amano, Yasuhiro Koh, et al.. (2007). Activity against Human Immunodeficiency Virus Type 1, Intracellular Metabolism, and Effects on Human DNA Polymerases of 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine. Antimicrobial Agents and Chemotherapy. 51(8). 2701–2708.
16.
Ghosh, Arun K., et al.. (2006). Bis‐Tetrahydrofuran: a Privileged Ligand for Darunavir and a New Generation of HIV Protease Inhibitors That Combat Drug Resistance. ChemMedChem. 1(9). 939–950.
17.
Ghosh, Arun K., Gary E. Schiltz, P. Sridhar, et al.. (2006). Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the P 2 ′
18.
Maeda, Kenji, Hirotomo Nakata, Hiromi Ogata, et al.. (2004). The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection. Current Opinion in Pharmacology. 4(5). 447–452.
19.
Yanada, Reiko, Yasuhiro Koh, Nobuaki Nishimori, et al.. (2004). Indium-Mediated Atom-Transfer and Reductive Radical Cyclizations of Iodoalkynes: Synthesis and Biological Evaluation of HIV-Protease Inhibitors. The Journal of Organic Chemistry. 69(7). 2417–2422.
20.
Maeda, Kenji, Hirotomo Nakata, Yasuhiro Koh, et al.. (2004). Spirodiketopiperazine-Based CCR5 Inhibitor Which Preserves CC-Chemokine/CCR5 Interactions and Exerts Potent Activity against R5 Human Immunodeficiency Virus Type 1 In Vitro. Journal of Virology. 78(16). 8654–8662.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by W. Gary Tarpley Breakdown of academic impact, for papers by Debananda Das Breakdown of academic impact, for papers by J C Quintero Breakdown of academic impact, for papers by Marc Witmer Breakdown of academic impact, for papers by Jill C. Heimbach Breakdown of academic impact, for papers by Manos Perros Breakdown of academic impact, for papers by Lori J. Gabryelski Breakdown of academic impact, for papers by William E. Kohlbrenner Breakdown of academic impact, for papers by Sudthida Vasavanonda Breakdown of academic impact, for papers by Simon Cocklin